GNRH1 and cartilage-hair hypoplasia: Subsequent therapy with GnRH pump or hCG/HMG was more likely to promote spermatogenesis, consistent with the current spermatogenesis rate of 64.0%–80.3% in CHH patients after treatment (29, 30).